FDA inspection
Shandong Anshun Pharmaceutical Co., Ltd.: FDA inspection ending Sep 22, 2023
FDA inspection 1220422 · No Action Indicated (NAI) · Dezhou
Key facts
| Inspection ID | 1220422 |
|---|---|
| Firm | Shandong Anshun Pharmaceutical Co., Ltd. |
| FEI number | 3015326904 |
| Address | Circular Economy Demonstration Park, Laoling |
| City | Dezhou |
| Country | China |
| Fiscal year | 2023 |
| Inspection end date | Sep 22, 2023 |
| Classification | No Action Indicated (NAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- None Citations
- None Posted citations
- No Warning letter followed
- No Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data